Thrombosis and Hemostasis Research

Thrombosis is a crucial hemostatic process for maintaining blood volume (hemostasis) following injury, yet aberrant thrombosis can trigger pathological conditions including myocardial infarction and stroke. Therefore the initiation of thrombosis is tightly controlled under physiological conditions.

Products for Thrombosis and Hemostasis Research - Page 15

Cat.No. Product Name Information/Activity
BCN2215 Arachidonic acid Arachidonic acid is an essential fatty acid and a major constituent of biomembranes.
BCC3952 AC 264613 PAR<sub>2</sub> receptor agonist
BCC3951 AC 55541 AC-55541 is a highly selective protease-activated receptor 2 (PAR2) agonist (pEC50=6.7), displays no activity at other PAR subtypes or at over 30 other receptors involved in nociception and inflammation. AC-55541 has pEC50 values of 5.9 and 6.6 in PI hydrolysis assays and Ca2+ mobilization assays and exhibits pronociceptive activity in vivo.
BCC3949 AY-NH2 PAR-4 Agonist Peptide, amide (PAR-4-AP; AY-NH2) is a proteinase-activated receptor-4 (PAR-4) agonist, which has no effect on either PAR-1 or PAR-2 and whose effects are blocked by a PAR-4 antagonist.
BCC3958 2-Furoyl-LIGRLO-amide 2-Furoyl-LIGRLO-amide is a potent and selective proteinase-activated receptor 2 (PAR2) agonist with a pD2 value of 7.0..
BCC3955 LRGILS-NH2 245329-01-5
BCC3954 RLLFT-NH2 447408-68-6
BCC3959 SLIGKV-NH2 Protease-Activated Receptor-2, amide (SLIGKV-NH2) is a highly potent protease-activated receptor-2 (PAR2) activating peptide.
BCC3947 SLIGRL-NH2 Protease-Activated Receptor-2 Activating Peptide is an agonist of Protease-Activated Receptor-2 (PAR-2).
BCC3948 TFLLR-NH2 TFLLR-NH2 is a selective PAR1 agonist with an EC50 of 1.9 μM.

Thrombosis and Hemostasis Research

Thrombosis and Hemostasis Research Products Targets

Products for Thrombosis and Hemostasis Research - Page 15